Table 2.
Clinical characteristics of COVID-19 subjects with or without olfactory and gustatory dysfunction (OGD)
| Characteristics | Females (n = 125) | Males (n = 72) | p value |
|---|---|---|---|
| Age, years, mean (SD) | 45.7 (14.2) | 47.8 (15) | 0.333 |
| (a) Loss of smell | |||
| Frequency, N (%) | 90 (72) | 48 (66.7) | 0.431 |
| Severity, VAS (0–10 cm), median [IQR] | 8 [10] | 6 [9.9] | 0.257 |
| Mild (> 0–3 cm), N (%) | 4 (4.4) | 4 (8.3) | 0.572 |
| Moderate (> 3–7 cm), N (%) | 20 (22.2) | 12 (25) | |
| Severe (> 7–10 cm), N (%) | 66 (73.3) | 32 (66.7) | |
| (b) Loss of taste | |||
| Frequency, N (%) | 89 (71.2) | 39 (54.2) | 0.016 |
| Severity, VAS (0–10 cm), median [IQR] | 7 [10] | 3.8 [8] | 0.014 |
| Mild (> 0–3 cm), N (%) | 5 (5.6) | 3 (7.7) | 0.791 |
| Moderate (> 3–7 cm), N (%) | 24 (27) | 12 (30.8) | |
| Severe (> 7–10 cm), N (%) | 60 (67.4) | 24 (61.5) | |
| (c) Loss of smell and taste | |||
| Frequency, N (%) | 85 (68) | 37 (51.4) | 0.021 |
COVID-19 coronavirus disease 2019, SD standard deviation, VAS visual analogue scale, IQR interquartile range